Milestone Pharmaceuticals Inc (MIST)

NASDAQ
Currency in USD
Disclaimer
3.000
0.000(0.00%)
Closed
After Hours
3.0000.000(0.00%)
Day's Range
2.9803.030
52 wk Range
2.6809.725
Prev. Close
3
Open
2.98
Day's Range
2.98-3.03
52 wk Range
2.68-9.725
Volume
44,558
Average Vol. (3m)
119,766
1-Year Change
-64.03%
Shares Outstanding
42,941,228
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
13.800
Upside +360.000%

People Also Watch

10.330
ROIV
+1.08%
2.660
XAIR
-5.00%
0.800
GOSS
-3.96%
15.820
CABA
-1.43%
1.951
SYPR
-1.49%

Milestone Pharmaceuticals Inc Company Profile

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company’s lead product candidate is etripamil, a novel and potent calcium channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. Milestone Pharmaceuticals Inc. has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.

Income Statement